Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Spruce Biosciences (SPRB) FCF Margin (2023 - 2024)

Spruce Biosciences (SPRB) has disclosed FCF Margin for 2 consecutive years, with 2966.57% as the latest value for Q4 2024.

  • Quarterly FCF Margin fell 258005.0% to 2966.57% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 892.83% through Sep 2025, up 154752.0% year-over-year, with the annual reading at 1139.56% for FY2024, 81004.0% down from the prior year.
  • FCF Margin for Q4 2024 was 2966.57% at Spruce Biosciences, down from 1532.06% in the prior quarter.
  • The five-year high for FCF Margin was 92.06% in Q2 2023, with the low at 2966.57% in Q4 2024.